Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial.
- 2022-01
- RCT
- Oxidative medicine and cellular longevity 2022(1)
- Mehrdokht Mazdeh
- Parnaz Abolfathi
- Maryam Sabetghadam
- Younes Mohammadi
- Maryam Mehrpooya
- PubMed: 35936217
- DOI: 10.1155/2022/2493053
- High evidence
- Clinical
The NIHSS score and mRS score on day 90 were improved by 5.82 and 0.94 scores, respectively, in the ALC-treated group compared to 2.83 and 0.11 scores, respectively, in the placebo-treated group, which demonstrated the superiority of ALC relative to placebo.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 1000 mg three times per day for three consecutive days